On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage
Continue Reading End of Semaglutide Shortage Means Big Changes for Prescribers and CompoundersOn December 11, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) published a Special Fraud Alert warning against suspect payment arrangements involving the Medicare Advantage
Continue Reading OIG Publishes Special Fraud Alert on Medicare Advantage Marketing Arrangements
On January 5, 2023, the Federal Trade Commission (“FTC”) published a Notice of Proposed Rulemaking (“NPRM”) which would broadly prohibit companies from entering into or enforcing non-competition agreements or clauses
Continue Reading FTC Proposes Broad Rule Banning Non-Compete Covenants with Physicians and Other Healthcare Workers
On July 11, Pennsylvania Governor Tom Wolf signed Senate Bill 818 (“SB 818”) into law, which amends the Health Care Facilities Act to expand the number of procedures that may
Continue Reading PA Health Care Facilities Act Amended to Permit More Procedures at Ambulatory Surgery Centers (ASCs) and Align with CMS Covered Procedures List